Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin i immunoassay

Clinical Chemistry and Laboratory Medicine

Volumn 56, Issue 1, 2017, Pages 157-161

  Lippi, Giuseppe ^a   Ferrari, Anna ^b   Gandini, Giorgio ^a   Gelati, Matteo ^b   Lo Cascio, Claudia ^b   Salvagno, Gian Luca ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

immunoassay; method evaluation; myocardial infarction; troponin

Indexed keywords

HEPARIN; LITHIUM; TROPONIN I;

ADULT; ARTICLE; BLOOD SAMPLING; FEMALE; HUMAN; IMMUNOASSAY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; BLOOD; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ADULT; FEMALE; HUMANS; IMMUNOASSAY; MALE; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 85031000313     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2017-0350     Document Type: Article

References (26)

1. Cervellin G, Mattiuzzi C, Bovo C, Lippi G. Diagnostic algorithms for acute coronary syndrome-is one better than another Ann Transl Med 2016;4:193.
2. Ferraro S, Panteghini M. Laboratory medicine as the science that underpins medicine: The "high-sensitivity" troponin paradigm. Clin Chem Lab Med 2015;53:653-64.
3. Lackner KJ. Do we really need high-sensitive troponin immunoassays in the emergency department Definitely, yes! Clin Chem Lab Med 2014;52:201-4.
4. Lippi G, Cervellin G. Cardiospecific troponin immunoassays: How low is it worth to go Eur J Intern Med 2016;30:e7-8.
5. Shah AS, Anand A, Sandoval Y, Lee KK, Smith SW, Adamson PD, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: A cohort study. Lancet 2015;386:2481-8.
6. Ferraro S, Dolci A, Panteghini M. Fast track protocols using highly sensitive troponin assays for ruling out and ruling in non-ST elevation acute coronary syndrome. Clin Chem Lab Med 2017;55:1683-9.
7. Lippi G. The mystifying nomenclature of cardiac troponin immunoassays. Scand J Clin Lab Invest 2014;74:273-7.
8. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61.
9. Lackner KJ. High-sensitivity assays for cardiac troponins. Clin Chem Lab Med 2015;53:631-3.
10. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009;55:573-7.
11. Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008;29 Suppl 1:S49-52.
12. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin Chem 1984;30:290-2.
13. Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory, 3rd ed. Document EP28-A3C. CLSI, Wayne, PA, USA, 2010.
14. Lippi G, Dipalo M, Avanzini P, Formentini A, Aloe R. Analytical assessment of the Beckman Coulter Unicel DxI AccuTnI3 immunoassay. Diagnosis 2014;1:195-7.
15. Arrebola MM, Lillo JA, Diez De Los Ríos MJ, Rodríguez M, Dayaldasani A, Yahyaoui R, et al. Analytical performance of a sensitive assay for cardiac troponin I with loci technology. Clin Biochem 2010;43:998-1002.
16. Clerico A, Fortunato A, Ripoli A, Prontera C, Zucchelli GC, Emdin M. Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations. Clin Chem Lab Med 2008;46:804-8.
17. Zeller T, Ojeda F, Brunner FJ, Peitsmeyer P, Münzel T, Binder H, et al. High-sensitivity cardiac troponin I in the general population-defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study. Clin Chem Lab Med 2015;53:699-706.
18. Krintus M, Kozinski M, Boudry P, Lackner K, Lefèvre G, Lennartz L, et al. Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I. Int J Cardiol 2015;187:256-63.
19. Schofer N, Brunner FJ, Schlüter M, Ojeda F, Zeller T, Baldus S, et al. Gender-specific diagnostic performance of a new high-sensitivity cardiac troponin I assay for detection of acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 2017;6:60-8.
20. Storti S, Masotti S, Prontera C, Franzini M, Buzzi P, Casagranda I, et al. Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI3 for the measurement of cardiac troponin I using both patients and quality control plasma samples. Clin Chim Acta 2015;451:129-34.
21. Clerico A, Ripoli A, Masotti S, Prontera C, Storti S, Fortunato A, et al. Pilot study on harmonization of cardiac troponin I immunoassays using patients and quality control plasma samples. On behalf of the Italian Section of the European Ligand Assay Society (ELAS) and of the Study Group on Cardiovascular Biomarkers of the Società Italiana di Biochimica Clinica (SIBioC). Clin Chim Acta 2016;456:42-8.
22. Lippi G, Cervellin G. Degradation of troponin I in serum or plasma: mechanisms, and analytical and clinical implications. Semin Thromb Hemost 2012;38:222-9.
23. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
24. Krintus M, Kozinski M, Boudry P, Capell NE, Köller U, Lackner K, et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT highly sensitive troponin I immunoassay. Clin. Chem Lab Med 2014;52:1657-65.
25. Casagranda I, Cavazza M, Clerico A, Galvani M, Ottani F, Zaninotto M, et al. Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation. Clin Chem Lab Med 2013;51:1727-37.
26. Lippi G. Biomarkers: Novel troponin immunoassay for early ACS rule-out. Nat Rev Cardiol 2016;13:9-10.